GREY:IPHAF - Post Discussion
Post by
culater on Feb 13, 2012 3:40pm
Compare to ONTY
Bought another Edmonton company, Biomira, around the same time as ISA some 10+ years ago. I pretty much wrote this investment off as well. Biomira packed their bags and headed to the U.S., changed the name to Oncothyreon Inc., did a reverse split, 1 share for 4 and trades on the NASDAQ. The info on the drugs seems similar to ISA in the development stage, but the past six months have presented an opportunity to at least break even on ONTY with constant activity. Better Management? Doesn't seem to be a whole lot better press on them. Any comments? culater
Be the first to comment on this post